Concepedia

Jill A. Lindia

JA

10

Publications

3.2K

Citations

10

H-Index

2003

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of California, San Francisco

University of Pittsburgh

Angeles Clinic and Research Institute

South Texas Accelerated Research Therapeutics

Jill A. Lindia is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and radiation oncology.

Top concepts

Publications per year

2003–2016

10

Publications

10

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

Antoni Ribas, Omid Hamid, Adil Daud et al. · JAMA · 2016 · 1K citations · Full text

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Amita Patnaik, Soonmo Peter Kang, Drew Rasco et al. · Clinical Cancer Research · 2015 · 767 citations

Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2

Catherine Abbadie, Jill A. Lindia, Anne Marie Cumiskey et al. · Proceedings of the National Academy of Sciences · 2003 · 585 citations · Full text

Contribution of the tetrodotoxin-resistant voltage-gated sodium channel Na <sub>V</sub> 1.9 to sensory transmission and nociceptive behavior

Birgit T. Priest, Beth Murphy, Jill A. Lindia et al. · Proceedings of the National Academy of Sciences · 2005 · 266 citations

Induction of CX3CL1 Expression in Astrocytes and CX3CR1 in Microglia in the Spinal Cord of a Rat Model of Neuropathic Pain

Jill A. Lindia, Erin McGowan, Nina Jochnowitz et al. · Journal of Pain · 2005 · 199 citations · Full text

, , +14

Rows per page

1–5 of 10